Intravitreal Ranibizumab Treatment of Central Serous Chorioretinopathy
Condition(s):Central Serous ChorioretinopathyLast Updated:November 2, 2008Completed
Hide Studies Not Open or Pending
Condition(s):Central Serous ChorioretinopathyLast Updated:November 2, 2008Completed
Condition(s):Central Serous ChorioretinopathyLast Updated:September 16, 2019Terminated
Condition(s):Acute Central Serous Retinopathy With Subretinal FluidLast Updated:September 13, 2022Completed
Condition(s):Central Serous ChorioretinopathyLast Updated:June 2, 2014Unknown status
Condition(s):Chronic Central Serous ChorioretinopathyLast Updated:June 15, 2016Unknown status
Condition(s):Central Serous ChoroidopathyLast Updated:July 18, 2019Completed
Condition(s):Chronic Central Serous ChorioretinopathyLast Updated:September 15, 2011Completed
Condition(s):Central Serous ChorioretinopathyLast Updated:January 4, 2007Unknown status
Condition(s):Central Serous Chorioretinopathy; Selective Retina TherapyLast Updated:September 30, 2009Completed
Condition(s):Chronic Central Serous ChorioretinopathyLast Updated:September 28, 2007Completed
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.